|
시장보고서
상품코드
2008949
심전도 텔레메트리 기기 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)ECG Telemetry Devices Market Report by Product (Event Monitoring and MCT, and Others), Application, End User, and Region 2026-2034 |
||||||
세계의 심전도 텔레메트리 기기 시장 규모는 2025년에 66억 달러에 달했습니다. 향후에 대해 IMARC Group은 2026-2034년에 CAGR 6.39%로 추이하며, 2034년까지 시장 규모가 117억 달러에 달할 것으로 예측하고 있습니다.
심전도(ECG) 원격 측정 기기는 심혈관 질환(CVD)이 의심되는 환자의 신속한 심전도 모니터링을 가능하게 합니다. 이들은 심장 조직에서 생성되는 전기적 임펄스를 감지하고 이를 파형으로 변환하는 데 도움을 줍니다. 병원 및 재택 의료 서비스에서 폭넓게 활용되고 있습니다. 현재 술, 담배, 비만, 운동 부족 등으로 인해 심근경색, 뇌졸중과 같은 심혈관 질환(CVD)의 유병률이 증가함에 따라 전 세계에서 심전도 원격 측정 기기에 대한 수요가 증가하고 있습니다.
심전도 텔레메트리 기기 시장 동향:
심전도 텔레메트리 기기는 심박수가 비정상적인 부정맥을 진단하고 치료하는 데 사용됩니다. 이 기기는 심장 리듬의 변동에 대한 정보를 제공하여 의사가 필요한 조치를 취할 수 있도록 도와줍니다. 이 외에도 심전도 텔레메트리 장비에는 관상동맥질환(CAD), 울혈성심부전(CHF) 등의 상태를 파악하기 위해 사용되는 안정시 심전도가 포함되어 있습니다. 이러한 상황과 더불어 의료 산업의 호황이 맞물려 시장 성장에 힘을 실어주고 있습니다. 또한 주택 분야에서 심전도계, 디지털 온도계, 자동 혈압계, 혈당 측정기, 체지방 측정기 등 건강 모니터링 기기의 이용이 크게 증가하고 있습니다. 이 장비들은 환자나 간병인이 최소한의 교육으로 조작할 수 있습니다. 또한 신종 코로나바이러스 감염증(COVID-19)은 심혈관계에 영향을 미쳐 심근 손상과 심장 기능 및 내피 기능 장애를 유발합니다. 여기에 고령 인구의 증가가 더해져 전 세계에서 심전도 원격 측정 기기에 대한 수요가 증가하고 있습니다. 기술 발전과 일반 대중의 심혈관 건강에 대한 인식 증가와 같은 다른 요인들도 향후 수년간 전체 매출과 수익성에 긍정적인 영향을 미칠 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 심전도 텔레메트리 기기 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSAThe global ECG telemetry devices market size reached USD 6.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 11.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.39% during 2026-2034.
Electrocardiography (ECG) telemetry devices enable rapid ECG monitoring of patients with suspected cardiovascular diseases (CVDs). They help detect electrical impulses generated by cardiac tissues, which are subsequently translated into waveforms. They find extensive applications in hospitals and home healthcare services. At present, the increasing prevalence of CVDs, such as heart attacks and strokes, due to alcohol and tobacco consumption, obesity, and physical inactivity among individuals is catalyzing the demand for ECG telemetry devices across the globe.
ECG TELEMETRY DEVICES MARKET TRENDS:
ECG telemetry devices are used in the diagnosis and treatment of arrhythmia wherein the heart rate of an individual becomes abnormal. These devices offer information about fluctuations in the rhythm of the heart that allows doctors to take required actions. Apart from this, ECG telemetry devices comprise resting ECGs, which are utilized for identifying conditions, such as coronary artery disease (CAD) or congestive heart failure (CHF). This, along with the thriving healthcare industry, is strengthening the growth of the market. Besides this, there is a significant rise in the utilization of health monitoring devices like electrocardiographs, digital thermometers, automatic blood pressure monitors, blood glucose monitors , and body fat monitors in the residential sector. They can be operated by patients or their caretakers with minimal training. Furthermore, coronavirus disease (COVID-19) affects the cardiovascular system and leads to myocardial damage and cardiac and endothelial dysfunction. This, coupled with the increasing geriatric population, is propelling the demand for ECG telemetry devices around the world. Other factors, including rising technological advancements and the growing awareness about cardiovascular health among the masses, are projected to influencing the overall sales and profitability positively in the coming years.
KEY MARKET SEGMENTATION:
Breakup by Product:
- Event Monitoring and MCT (Mobile Cardiac Telemetry)
- Others
Breakup by Application:
- Arrhythmias
- Myocardial Ischemia and Infarction
- Pacemaker Monitoring
- Others
Breakup by End User:
- Hospitals
- Home Healthcare
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report provides a comprehensive analysis of the competitive landscape in the global ECG telemetry devices market with detailed profiles of all major companies, including:
- Aerotel Medical Systems (1998) Ltd
- Baxter International Inc.
- Boston Scientific Corporation
- GE HealthCare
- Koninklijke Philips N.V.
- Medicalgorithmics S.A.
- Mindray Medical India Pvt. Ltd
- Nihon Kohden Corporation
- Norav Medical
- ScottCare
- ZOLL Medical Corporation
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global ECG telemetry devices market in 2025?
2. What is the expected growth rate of the global ECG telemetry devices market during 2026-2034?
3. What has been the impact of COVID-19 on the global ECG telemetry devices market?
4. What are the key factors driving the global ECG telemetry devices market?
5. What is the breakup of the global ECG telemetry devices market based on the product?
6. What is the breakup of the global ECG telemetry devices market based on the application?
7. What are the key regions in the global ECG telemetry devices market?
8. Who are the key players/companies in the global ECG telemetry devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global ECG Telemetry Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Event Monitoring and MCT (Mobile Cardiac Telemetry)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Others
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Arrhythmias
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Myocardial Ischemia and Infarction
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Pacemaker Monitoring
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Home Healthcare
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Aerotel Medical Systems (1998) Ltd
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Baxter International Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Boston Scientific Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 GE HealthCare
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Koninklijke Philips N.V.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Medicalgorithmics S.A.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Mindray Medical India Pvt. Ltd
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Nihon Kohden Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Norav Medical
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 ScottCare
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 ZOLL Medical Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 SWOT Analysis
- 14.3.1 Aerotel Medical Systems (1998) Ltd
